BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 25303977)

  • 21. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
    Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
    J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma.
    Thind AS; Ashford B; Strbenac D; Mitchell J; Lee J; Mueller SA; Minaei E; Perry JR; Ch'ng S; Iyer NG; Clark JR; Gupta R; Ranson M
    Front Oncol; 2022; 12():919118. PubMed ID: 35982973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
    Nissinen L; Farshchian M; Riihilä P; Kähäri VM
    Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.
    Oberholzer PA; Kee D; Dziunycz P; Sucker A; Kamsukom N; Jones R; Roden C; Chalk CJ; Ardlie K; Palescandolo E; Piris A; MacConaill LE; Robert C; Hofbauer GF; McArthur GA; Schadendorf D; Garraway LA
    J Clin Oncol; 2012 Jan; 30(3):316-21. PubMed ID: 22067401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Squamous Cell Carcinomas Identifies
    Machnicki MM; Rzepakowska A; Janowska JI; Pepek M; Krop A; Pruszczyk K; Stawinski P; Rydzanicz M; Grzybowski J; Gornicka B; Wnuk M; Ploski R; Osuch-Wojcikiewicz E; Stoklosa T
    Front Oncol; 2022; 12():768954. PubMed ID: 35664801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Huaier Inhibits Proliferation, Migration, and Invasion of Cutaneous Squamous Cell Carcinoma Cells by Inhibiting the Methylation Levels of CDKN2A and TP53.
    Wang L; Xu L; Wang Y
    Integr Cancer Ther; 2021; 20():15347354211031646. PubMed ID: 34291682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
    Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
    Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
    World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.
    Al-Rohil RN; Tarasen AJ; Carlson JA; Wang K; Johnson A; Yelensky R; Lipson D; Elvin JA; Vergilio JA; Ali SM; Suh J; Miller VA; Stephens PJ; Ganesan P; Janku F; Karp DD; Subbiah V; Mihm MC; Ross JS
    Cancer; 2016 Jan; 122(2):249-57. PubMed ID: 26479420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transposon mutagenesis identifies cooperating genetic drivers during keratinocyte transformation and cutaneous squamous cell carcinoma progression.
    Aiderus A; Newberg JY; Guzman-Rojas L; Contreras-Sandoval AM; Meshey AL; Jones DJ; Amaya-Manzanares F; Rangel R; Ward JM; Lee SC; Ban KH; Rogers K; Rogers SM; Selvanesan L; McNoe LA; Copeland NG; Jenkins NA; Tsai KY; Black MA; Mann KM; Mann MB
    PLoS Genet; 2021 Aug; 17(8):e1009094. PubMed ID: 34398873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma.
    Nakagaki T; Tamura M; Kobashi K; Omori A; Koyama R; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
    Tumour Biol; 2018 Sep; 40(9):1010428318800180. PubMed ID: 30226113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene.
    Lambert SR; Harwood CA; Purdie KJ; Gulati A; Matin RN; Romanowska M; Cerio R; Kelsell DP; Leigh IM; Proby CM
    Int J Cancer; 2012 Aug; 131(3):E216-26. PubMed ID: 22052591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive genomic characterization of head and neck squamous cell carcinomas.
    Cancer Genome Atlas Network
    Nature; 2015 Jan; 517(7536):576-82. PubMed ID: 25631445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular prediction of metastasis in cutaneous squamous cell carcinoma.
    Mulvaney PM; Schmults CD
    Curr Opin Oncol; 2020 Mar; 32(2):129-136. PubMed ID: 31850970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
    Li F; Liao J; Duan X; He Y; Liao Y
    J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.
    Mountzios G; Rampias T; Psyrri A
    Ann Oncol; 2014 Oct; 25(10):1889-1900. PubMed ID: 24718888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.